South Africa's Aspen finalizes GSK deal for $263 million
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) said on Monday it has finalized the acquisition of medicines from GlaxoSmithKline (GSK.L) for 163.8 million pounds ($263 million).
The deal, announced in August, was initially pegged at 172 million pounds.
($1 = 0.6240 British pounds)
(Reporting by Olivia Kumwenda; editing by David Dolan)
- U.S. small businesses borrowed more money in January than they did a year earlier, signaling continued growth in the economy despite a spate of cold weather that has been blamed for weakness in many other indicators of activity.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.